Note 9 - Other Expenses - Components of Research and Development Expenses (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
|
Statement Line Items [Line Items] | ||||
Program costs, excluding salaries | $ 2,201 | $ 692 | $ 4,476 | $ 1,939 |
Salaries | 457 | 314 | 946 | 743 |
License fee, CrystalGenomics (note 9(a),(b)) | 5,000 | 5,000 | ||
Stock-based compensation | 152 | 73 | 519 | 123 |
Depreciation and amortization | 8 | 9 | 17 | 18 |
$ 7,818 | $ 1,088 | $ 10,958 | $ 2,823 |
X | ||||||||||
- Definition Amount of research and development expense excluding salaries. No definition available.
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to depreciation included in research or development activities, recognised in profit or loss. No definition available.
|
X | ||||||||||
- Definition The license fee presented as a component of research and development expense. No definition available.
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to salaries included in research or development activities, recognised in profit or loss. No definition available.
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to stock-based compensation included in research or development activities, recognised in profit or loss. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|